Biomarkers are molecular substances in the body that can be used to indicate health or disease. These biomarkers can be found in tissue, blood, urine and other body fluids. Prostate and ovarian cancers are two examples of how the use of biomarkers can lead to individualized diagnosis and treatment.
The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical question, and answers it through a four-phase approach: Discovery, experimental validation, preclinical validation and clinical validation.
Discover the latest in Biomarkers, and Genomics, at our annual Individualizing Medicine Conference this year, October 6-8!